HCG
Human Chorionic Gonadotropin
HCG (Human Chorionic Gonadotropin) Research Protocol
Quickstart Overview
HCG is a glycoprotein hormone that mimics luteinizing hormone (LH) at its receptor. In men it directly stimulates testicular Leydig cells to produce testosterone and maintain testicular size and fertility — the basis of its use alongside testosterone therapy and in fertility research.
Scientific Data
Dosing & Reconstitution Guide
Units assume a U-100 insulin syringe (100 units = 1 mL). Dosed in IU, not mg. Reconstitute per the vial's IU and refrigerate.
Reconstitution Steps
- 1Allow the lyophilized vial and bacteriostatic water to reach room temperature (~15 min).
- 2Swab both vial stoppers with a fresh 70% isopropyl alcohol pad and let them dry.
- 3Draw 5.0 mL of bacteriostatic water into a mixing syringe.
- 4Insert at an angle and let the water run slowly down the glass wall — never directly onto the powder.
- 5Gently swirl (do not shake) until the solution is completely clear.
- 6Label with date and concentration (mg/mL) and refrigerate at 2–8 °C immediately.
Supplies Needed
Planning example for a 8-week protocol at approximately 500 mcg per day.
Protocol Overview
Dosing Protocol
Storage Instructions
Important Notes
- Dosed in international units (IU), not milligrams.
- Monitor oestrogen — HCG can increase aromatisation.
How This Works
HCG binds the LH/HCG receptor on testicular Leydig cells (and ovarian cells), driving testosterone synthesis and, with FSH support, spermatogenesis. Because it acts directly at the gonad (downstream of the pituitary), it maintains testicular function even when the HPG axis is suppressed by exogenous testosterone — preventing the atrophy and infertility that otherwise accompany TRT. It is also used to trigger ovulation in fertility protocols.
Potential Benefits & Side Effects
- Direct stimulation of testicular testosterone production
- Maintenance of testicular size and fertility on TRT
- Ovulation trigger in fertility protocols
- Restoration of function after HPG suppression
- Injection-site reactions
- Possible oestrogen rise (aromatisation) → monitor
- Gynecomastia or water retention at higher doses
- Acne or mood changes
Lifestyle Factors
- Adequate hydration and 7–9 h of sleep are standard controls in most research protocols.
- Consistent dose timing improves the reliability of any self-tracked endpoints.
- Maintain a clean, sterile workflow for every draw to avoid contamination.
Injection Technique
- 1Wash hands, then prep the vial top and the target site with separate alcohol swabs.
- 2Pinch a subcutaneous skin fold (abdomen, ~2 inches from the navel) and insert at 45–90°.
- 3Depress the plunger slowly over 3–5 seconds, hold 5 seconds, then withdraw.
- 4Rotate sites each administration and dispose of the syringe in a sharps container.
Frequently Asked Questions
CG Labz Verified Batches
No published batches yet.
Research Disclaimer
All compounds are supplied strictly for laboratory research. Dosing figures below summarize ranges reported in published preclinical and clinical literature for reference purposes only. CG Labz does not provide medical advice or individualized dosing recommendations.
References
- [1] Journal of Clinical Endocrinology & MetabolismCoviello A.D. et al. Low-dose HCG maintains intratesticular testosterone.View Source